These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22609591)
21. Incorporation of PLGA nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior. Nandagiri VK; Gentile P; Chiono V; Tonda-Turo C; Matsiko A; Ramtoola Z; Montevecchi FM; Ciardelli G J Mech Behav Biomed Mater; 2011 Oct; 4(7):1318-27. PubMed ID: 21783141 [TBL] [Abstract][Full Text] [Related]
22. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles. Chung TW; Wang SS; Tsai WJ Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984 [TBL] [Abstract][Full Text] [Related]
23. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen. Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455 [TBL] [Abstract][Full Text] [Related]
24. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method. Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303 [TBL] [Abstract][Full Text] [Related]
25. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis. Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875 [TBL] [Abstract][Full Text] [Related]
26. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292 [TBL] [Abstract][Full Text] [Related]
27. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Chu CH; Wang YC; Huang HY; Wu LC; Yang CS Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469 [TBL] [Abstract][Full Text] [Related]
28. Platelet compatibility of PLGA, chitosan and PLGA-chitosan nanoparticles. Li X; Radomski A; Corrigan OI; Tajber L; De Sousa Menezes F; Endter S; Medina C; Radomski MW Nanomedicine (Lond); 2009 Oct; 4(7):735-46. PubMed ID: 19839810 [TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents. Manchanda R; Fernandez-Fernandez A; Nagesetti A; McGoron AJ Colloids Surf B Biointerfaces; 2010 Jan; 75(1):260-7. PubMed ID: 19775872 [TBL] [Abstract][Full Text] [Related]
30. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery. Wang Y; Li P; Kong L AAPS PharmSciTech; 2013 Jun; 14(2):585-92. PubMed ID: 23463262 [TBL] [Abstract][Full Text] [Related]
31. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles. Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573 [TBL] [Abstract][Full Text] [Related]
32. Microscopic and spectroscopic evaluation of novel PLGA-chitosan Nanoplexes as an ocular delivery system. Jain GK; Pathan SA; Akhter S; Jayabalan N; Talegaonkar S; Khar RK; Ahmad FJ Colloids Surf B Biointerfaces; 2011 Feb; 82(2):397-403. PubMed ID: 20940097 [TBL] [Abstract][Full Text] [Related]
33. Interfacial properties of hydrophilized poly(lactic-co-glycolic acid) layers with various thicknesses. Gyulai G; Pénzes CB; Mohai M; Lohner T; Petrik P; Kurunczi S; Kiss É J Colloid Interface Sci; 2011 Oct; 362(2):600-6. PubMed ID: 21777919 [TBL] [Abstract][Full Text] [Related]
34. Engineering of Δ9-tetrahydrocannabinol delivery systems based on surface modified-PLGA nanoplatforms. Martín-Banderas L; Muñoz-Rubio I; Álvarez-Fuentes J; Durán-Lobato M; Arias JL; Holgado MÁ; Fernández-Arévalo M Colloids Surf B Biointerfaces; 2014 Nov; 123():114-22. PubMed ID: 25262411 [TBL] [Abstract][Full Text] [Related]
35. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. Nie H; Wang CH J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077 [TBL] [Abstract][Full Text] [Related]
36. Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles. Manca ML; Loy G; Zaru M; Fadda AM; Antimisiaris SG Colloids Surf B Biointerfaces; 2008 Dec; 67(2):166-70. PubMed ID: 18835764 [TBL] [Abstract][Full Text] [Related]
37. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo. Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K Colloids Surf B Biointerfaces; 2012 Apr; 92():50-4. PubMed ID: 22154100 [TBL] [Abstract][Full Text] [Related]